Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
A cold and blustery day gives way to a cold and blustery night. Happily, a warm dinner awaits. Until tomorrow....or something else comes up....
CV Therapeutics Drug Fails Trial, Stock Dives After Hours;
Study Shows Big Jump In Global ADHD Drug Use;
Wyeth And Progenics Take Another Look At Constipation;
Baucus And Grassley Ask FDA To Explain Botched Computer System.
